Whitepaper: Digitizing regulatory affairs: The future of automation
Our latest whitepaper (in partnership with DXC) examines the current state of technological adoption in regulatory affairs, the solutions that are emerging, the opportunities they present, and the challenges faced in adopting them.

Access the full whitepaper below to find out how leaders in the regulatory function are adopting digital-first approaches

This whitepaper was created as part of Reuters Events Pharma 2022 (formerly eyeforpharma Barcelona), 11 - 13 October, 2022 Nice, France the biggest, most senior and cross-functional commercial pharma event.
Discover the full agenda and speaker line-up to find out more >>>
*Can't see the PDF? Click here
Do you want to deep-dive into the topics covered in this whitepaper with your peers? The whitepaper was created alongside our interactive workshop on April 28 at 11am ET, hosted with our partners DXC Technology. Join this 60-minute problem solving discussion to learn how to truly transform the regulatory function. Apply to join the workshop here.
For more insights, join us at Reuters Events Pharma 2022 (formerly eyeforpharma Barcelona), 11 - 13 October, 2022 Nice, France the biggest, most senior and cross-functional commercial pharma event. We may have come off the year of the vaccine, but we’re just beginning the decade of pharma’s awakening.
Discover the full agenda and speaker line-up to find out more >>>
Kind regards,
Be the first to discover our ground-breaking 2022 event line-up!  

Pre-order your agenda and speaker line-up now!
Join the 2000+ pharma industry leaders who will be joining us in Nice for the most influential pharma event of the year. Fill in your details below to join the waitlist for the full agenda and speaker line-up:

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.